We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




A Novel Fluorescent Marker System Labels Replicating Cells in Vivo

By LabMedica International staff writers
Posted on 10 Dec 2012
A strain of mice was genetically engineered to express a fluorescent label in cells that were dividing, which allowed them to be isolated and analyzed.

Until now, the isolation and study of replicating cells from living animals typically involved immunostaining for intracellular markers of proliferation, causing the loss of sensitive biological material. More...
This situation has been greatly improved by investigators at the Hebrew University of Jerusalem (Israel) who genetically engineered a line of mice to express a green fluorescent CyclinB1-GFP fusion reporter that marked replicating cells in the S/G2/M phases of the cell cycle. The green color disappeared upon completion of cell division.

The investigators employed flow cytometry to isolate live replicating cells from the livers of the genetically engineered mice and compared their transcriptome to that of quiescent cells to reveal gene expression programs associated with in vivo cell proliferation.

They reported in the September 20, 2012, online edition of the journal Developmental Cell that replicating hepatocytes had reduced expression of genes characteristic of liver differentiation. Thus, in the replicating liver cells there was a significant decrease in the expression of genes responsible for key liver functions such as fatty acid and amino acid metabolism.

The investigators concluded that when differentiated cells divide, they temporarily shift to a less differentiated state. This condition is similar to that of cancer cells, which are less differentiated than normal cells and proliferate rapidly.

The fluorescent cell replication reporter system was shown to provide a powerful platform for gene expression and metabolic and functional studies of dividing cells in their in vivo niche.

Related Links:

Hebrew University of Jerusalem




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.